AVAILABLE MEDICINE FOR Dapagliflozin
There are no products to list.
Introduction to Dapagliflozin
Dapagliflozin is indicated for the treatment of type 2 diabetes mellitus and heart failure. It inhibits renal glucose reabsorption by the SGLT2 transporter and increases excretion of glucose in the urine, which reduces blood sugar levels.
This drug usually accompanies diet and exercise. Clinical trials have demonstrated that, in addition to providing glycemic control, dapagliflozin offers cardiovascular protection through the reduction of risk for hospitalization due to heart failure in at-risk patients. Common adverse effects include urinary tract infections, genital fungal infections, and dehydration. It is important that the patient remains well hydrated during the treatment period with dapagliflozin and informs immediately in case of any suspicion of infection. It is normally taken once daily, with or without food, and may be a very important part of an overall diabetes management program. Like all medications, frequent monitoring of blood glucose levels is necessary to ascertain the response to this medication. Physicians will also monitor renal function before and during treatment, as dapagliflozin can affect kidney health. Side effects must be adequately discussed with every patient, and their cooperation about compliance with medication is to be assured for the best possible outcomes.
